ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. - Balmanno K; Kidger AM; Byrne DP; Sale MJ; Nassman N; Eyers PA; Cook SJ (The Biochemical journal, 2023)